Publications 2026

Download Publication

Last updated September 4, 2026

Stay Informed with DermaSensor post

Get the latest insights from DermaSensor straight to your inbox. Subscribe to receive news, events, case studies and whitepapers.

Get the latest insights from DermaSensor straight to your inbox. Subscribe to receive news, events, and documents.

Indications for Use

The DermaSensor device is indicated for evaluating skin lesions suggestive of melanoma, basal cell carcinoma, and/or squamous cell carcinoma in patients aged 40 and above, to assist in the decision to refer the patient to a dermatologist. The DermaSensor device should be used in conjunction with the totality of clinically relevant information from the clinical assessment, including visual analysis of the lesion, by physicians who are not dermatologists. The device should be used on lesions already assessed as suspicious for skin cancer and not as a screening tool. The device should not be used as the sole diagnostic criterion nor to confirm clinical diagnosis of skin cancer.

Primary Care Health Systems Specialty Care Value-based Care Membership-based Care Skin Cancer Detection Device

Technology Evidence Workflow

Publications Videos Webinars Podcasts

Contact Us Our Story Leadership Team Board Members Scientific Advisors

Press Releases Events Webinar

Our Stories

Reimbursement Support Product Education